Medroxyprogesterone 17-acetate

Target genes for Medroxyprogesterone 17-acetate is obtained based on ToxCast assay component endpoints.
Chemical nameGene identifierToxCast assay component endpoint name
Medroxyprogesterone 17-acetateCSF1BSK_CASM3C_MCSF_up
Medroxyprogesterone 17-acetateCSF1BSK_hDFCGF_MCSF_up
Medroxyprogesterone 17-acetateCYP2C19NVS_ADME_hCYP2C19
Medroxyprogesterone 17-acetateCYP2C9NVS_ADME_hCYP2C9
Medroxyprogesterone 17-acetateCYP3A4NVS_ADME_hCYP3A4
Medroxyprogesterone 17-acetateEGR1ATG_EGR_CIS_up
Medroxyprogesterone 17-acetateESR1ATG_ERE_CIS_up
Medroxyprogesterone 17-acetateESR2TOX21_ERb_BLA_Antagonist_ratio
Medroxyprogesterone 17-acetateESRRATOX21_ERR_Antagonist
Medroxyprogesterone 17-acetateESRRATOX21_PGC_ERR_Antagonist
Medroxyprogesterone 17-acetateNR3C1TOX21_GR_BLA_Antagonist_ratio
Medroxyprogesterone 17-acetateNR3C1NVS_NR_hGR
Medroxyprogesterone 17-acetateNR3C1ATG_GR_TRANS_up
Medroxyprogesterone 17-acetateNR3C1TOX21_GR_BLA_Agonist_ratio
Medroxyprogesterone 17-acetateHLA-DRABSK_3C_HLADR_down
Medroxyprogesterone 17-acetateHLA-DRABSK_BE3C_HLADR_down
Medroxyprogesterone 17-acetateIL6BSK_CASM3C_IL6_down
Medroxyprogesterone 17-acetateCXCL8BSK_CASM3C_IL8_down
Medroxyprogesterone 17-acetateCXCL10BSK_KF3CT_IP10_up
Medroxyprogesterone 17-acetateIRF1ATG_ISRE_CIS_dn
Medroxyprogesterone 17-acetateARTOX21_AR_BLA_Antagonist_ratio
Medroxyprogesterone 17-acetateARNVS_NR_hAR
Medroxyprogesterone 17-acetateARTOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide
Medroxyprogesterone 17-acetateARATG_AR_TRANS_up
Medroxyprogesterone 17-acetateARTOX21_AR_LUC_MDAKB2_Agonist
Medroxyprogesterone 17-acetateARTOX21_AR_BLA_Agonist_ratio
Medroxyprogesterone 17-acetateJUNTOX21_AP1_BLA_Agonist_ratio
Medroxyprogesterone 17-acetateLDLRBSK_CASM3C_LDLR_up
Medroxyprogesterone 17-acetateFOSTOX21_AP1_BLA_Agonist_ratio
Medroxyprogesterone 17-acetateMMP1BSK_BE3C_MMP1_up
Medroxyprogesterone 17-acetateMMP9NVS_ENZ_hMMP9
Medroxyprogesterone 17-acetateMTF1ATG_MRE_CIS_up
Medroxyprogesterone 17-acetateNFE2L2ATG_NRF2_ARE_CIS_up
Medroxyprogesterone 17-acetateNFE2L2TOX21_ARE_BLA_agonist_ratio
Medroxyprogesterone 17-acetateNFKB1ATG_NF_kB_CIS_dn
Medroxyprogesterone 17-acetateNR4A2ATG_NURR1_TRANS_up
Medroxyprogesterone 17-acetateSERPINE1BSK_hDFCGF_PAI1_up
Medroxyprogesterone 17-acetatePAX6ATG_Pax6_CIS_up
Medroxyprogesterone 17-acetateLEF1ATG_TCF_b_cat_CIS_dn
Medroxyprogesterone 17-acetatePGRTOX21_PR_BLA_Agonist_ratio
Medroxyprogesterone 17-acetatePGRTOX21_PR_BLA_Antagonist_ratio
Medroxyprogesterone 17-acetatePGRNVS_NR_hPR
Medroxyprogesterone 17-acetatePPARGATG_PPARg_TRANS_up
Medroxyprogesterone 17-acetateRARAATG_RARa_TRANS_dn
Medroxyprogesterone 17-acetateRORAATG_RORE_CIS_up
Medroxyprogesterone 17-acetateRORBATG_RORE_CIS_up
Medroxyprogesterone 17-acetateRORCATG_RORE_CIS_up
Medroxyprogesterone 17-acetateRXRAATG_RXRa_TRANS_up
Medroxyprogesterone 17-acetateRXRBATG_RXRb_TRANS_up
Medroxyprogesterone 17-acetateSAA1BSK_CASM3C_SAA_up
Medroxyprogesterone 17-acetateCCL2BSK_CASM3C_MCP1_down
Medroxyprogesterone 17-acetateTCF7ATG_TCF_b_cat_CIS_dn
Medroxyprogesterone 17-acetateTCF7L2ATG_TCF_b_cat_CIS_dn
Medroxyprogesterone 17-acetateTP53ATG_p53_CIS_dn
Medroxyprogesterone 17-acetateVDRATG_VDRE_CIS_up
Medroxyprogesterone 17-acetateTCF7L1ATG_TCF_b_cat_CIS_dn
Medroxyprogesterone 17-acetateNR1I2ATG_PXR_TRANS_up
Medroxyprogesterone 17-acetateNR1I2ATG_PXRE_CIS_up
Medroxyprogesterone 17-acetateNR1H4TOX21_FXR_BLA_antagonist_ratio

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.